Business Segments Chongqing Zhifei Biological Products Co., Ltd.
Equities
300122
CNE100000V20
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.03 CNY | -1.22% |
|
+1.54% | -4.83% |
Dec. 09 | Chongqing Zhifei Biological, GSK Adjust Terms of Cooperation Agreement | MT |
Dec. 05 | GSK, China's Zhifei Extend Shingles Shot Collaboration to 2034 | DJ |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Biochemical Product | 10.53B | 15.16B | 30.63B | 38.26B | 52.91B | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Unallocated Others | 61.91M | 34.23M | 23.46M | 3.85M | 4.08M |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
East China | 3.47B | 5.19B | 9.55B | 12.99B | 18.48B | |||||
South China | 1.7B | 2.44B | 4.36B | 7.53B | 9B | |||||
Southwest China | 1.37B | 1.83B | 4.12B | 5.04B | 7.23B | |||||
North China | 1.53B | 2.1B | 4.7B | 4.05B | 6.99B | |||||
Central China | 1.76B | 2.4B | 4.77B | 5.59B | 6.48B | |||||
Northwest China | 318M | 634M | 1.11B | 1.64B | 3.07B | |||||
Northeast China | 428M | 591M | 890M | 1.44B | 1.66B | |||||
Export | 11.68M | 11.93M | 1.16B | -463K | 9.23M | |||||
China | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |